Italian Laboratory Expands ProtoKinetix' Market for AAGP(TM)MarketWatch (press release)This significant increase in yield, will result in major cost reductions for the treatment of cardio vascular disease, auto-immune disorders, leukemia, transplan…
Capital Research Global Investors' Q3 Healthcare Stock AllocationsWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejecti…
A Pension Fund's Largest Healthcare Share Holdings: JNJ, UNH, MRK, AMGN, NVS …Wall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ tran…
mobihealthnewsDr Topol: Haven't used a stethoscope in 2 yearsmobihealthnewsTopol's keynote also included a hypothetical “Apps of the Future” discussion which include genetically-tailored apps for heart attack risk, cancer detection, and tra…
Research and Markets: Monoclonal Antibodies Market to 2017 – Monoclonal …Benzinga (press release)The first FDA-approved therapeutic monoclonal antibody was a murine IgG2a CD3 specific transplant rejection drug, OKT3 (also called muromonab) in 1986. T…
InPharmBig pharma: big rewards come from big risksInPharmThis effort produced tofacitinib, a very exciting, first-in-class small molecule to treat rheumatoid arthritis, psoriasis and may prove to be valuable in preventing organ transplant rejection. I …
McKnight’s Long Term Care NewsFDA approved 35 new drugs during the latest fiscal yearMcKnight’s Long Term Care NewsAlmost half were found to be significant therapeutic advances over existing therapies for heart attack, stroke or kidney transplant rejec…
Insiders are Selling These Stocks on Dec-1Beacon Equity Research… Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threatening disease states, including hematologic and neurologic diseases, transplan…
Reimbursement in Personalized MedicineGenetic Engineering News“Gaining FDA clearance for AlloMap® (a noninvasive assay to manage the risk of heart transplant rejection) did nothing for reimbursement or clinical adoption. Instead, outcome studies to …
Gardner Russo Gardner Lowers Abbott Labs Shares, Starts Medtronic and Pfizer …Wall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transpla…